Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Boehringer Ingelheim
Baxter
McKesson
AstraZeneca

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018150

See Plans and Pricing

« Back to Dashboard

NDA 018150 describes THALLOUS CHLORIDE TL 201, which is a drug marketed by Bracco, Curium, Ge Healthcare, Lantheus Medcl, Trace Life, and Mallinkrodt Nuclear, and is included in six NDAs. It is available from three suppliers. Additional details are available on the THALLOUS CHLORIDE TL 201 profile page.

The generic ingredient in THALLOUS CHLORIDE TL 201 is thallous chloride tl-201. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the thallous chloride tl-201 profile page.
Summary for 018150
Tradename:THALLOUS CHLORIDE TL 201
Applicant:Curium
Ingredient:thallous chloride tl-201
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018150
Mechanism of ActionRadiopharmaceutical Activity
Suppliers and Packaging for NDA: 018150
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INJECTION 018150 NDA Curium US LLC 69945-120 69945-120-28 1 VIAL in 1 CAN (69945-120-28) > 2.8 mL in 1 VIAL
THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INJECTION 018150 NDA Curium US LLC 69945-120 69945-120-56 1 VIAL in 1 CAN (69945-120-56) > 5.6 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1mCi/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Boehringer Ingelheim
AstraZeneca
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.